Anna-pia Papageorgiou
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation.
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation.
Journal: Journal of cellular and molecular medicine
Published: July 22, 2020
AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism.
Journal: Basic research in cardiology
Published: May 28, 2020
Extracellular SPARC increases cardiomyocyte contraction during health and disease.
Journal: PloS one
Published: December 04, 2018
SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: February 08, 2018
Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: May 14, 2017
Aberrant Collagen Composition of the Trabecular Meshwork Results in Reduced Aqueous Humor Drainage and Elevated IOP in MMP-9 Null Mice.
Journal: Investigative ophthalmology & visual science
Published: November 08, 2016
Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
Journal: Circulation
Published: June 25, 2016
The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis.
Journal: European heart journal
Published: February 24, 2016
Novel regulators of cardiac inflammation: Matricellular proteins expand their repertoire.
Journal: Journal of molecular and cellular cardiology
Published: October 01, 2015
Metabolic support for the heart: complementary therapy for heart failure?
Journal: European journal of heart failure
Published: October 01, 2015
Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.
Journal: Circulation research
Published: December 19, 2014
Last Updated: 09/26/2026